| 51 |
14686975 | Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma. | 2003 |
3 |
| 52 |
15202526 | Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches. | 2003 |
2 |
| 53 |
11902983 | Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma. | 2002 Mar |
2 |
| 54 |
11978140 | Treatment of cutaneous T cell lymphoma: current status and future directions. | 2002 |
2 |
| 55 |
12006543 | Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. | 2002 May |
5 |
| 56 |
12399758 | Optimizing bexarotene therapy for cutaneous T-cell lymphoma. | 2002 Nov |
2 |
| 57 |
12847736 | Treatment of mycosis fungoides with oral bexarotene combined with PUVA. | 2002 Sep |
1 |
| 58 |
11331325 | Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. | 2001 May 1 |
1 |
| 59 |
11520254 | Therapeutic advances in biological response modifiers in the treatment of cutaneous T-cell lymphoma. | 2001 |
1 |
| 60 |
11573857 | Oral bexarotene in the treatment of cutaneous T-cell lymphoma. | 2001 Sep |
5 |
| 61 |
11705358 | Cutaneous T-cell lymphoma. New immunomodulators. | 2001 Oct |
1 |
| 62 |
11249708 | Bexarotene ligand pharmaceuticals. | 2000 Dec |
2 |
| 63 |
11702369 | Bexarotene. | 2000 Jul-Aug |
2 |
| 64 |
11707864 | The treatment of cutaneous T-cell lymphoma with a novel retinoid. | 2000 Nov |
2 |